Swedencare AB (publ) Stock Nasdaq Stockholm
Stocks
SE0008294078
Pharmaceuticals
OTC Markets Traded
| Market Cap | 4.16B 434M 378M 350M 328M 614M 40.94B 619M 1.61B 20.13B 1.63B 1.59B 70.52B | P/E 2026 * |
24.8x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 5.62B 587M 511M 473M 443M 830M 55.33B 836M 2.17B 27.21B 2.2B 2.15B 95.31B | EV / Sales 2026 * |
1.97x | EV / Sales 2027 * | 1.74x |
| Free-Float |
30.51% | Yield 2026 * |
1.82% | Yield 2027 * | 2.78% |
Last Transcript: Swedencare AB (publ)
| 1 day | -4.16% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2013-12-31 | |
Jenny Graflind
CEO | Chief Executive Officer | 50 | 2019-10-31 |
Annie Bengtsson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 59 | 2025-12-31 | |
| Director/Board Member | 63 | 2018-12-31 | |
Johan Bergdahl
BRD | Director/Board Member | 56 | 2013-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.16% | -5.47% | - | - | 435M | |
| +1.88% | -3.30% | -49.24% | -53.90% | 33B | |
| +3.55% | +0.71% | +81.70% | +133.56% | 12.1B | |
| -2.44% | -4.58% | +0.74% | +20.81% | 4.36B | |
| +3.34% | -0.58% | +6.74% | +17.21% | 3.17B | |
| -1.09% | -1.34% | +57.77% | +22.35% | 1.9B | |
| -3.27% | -0.67% | -26.07% | -6.03% | 1.64B | |
| +3.27% | +1.89% | +32.93% | +130.46% | 1.29B | |
| -0.65% | +0.80% | -22.92% | -12.84% | 1.02B | |
| -1.09% | -3.93% | -10.80% | -47.83% | 961M | |
| Average | -0.07% | -2.74% | +7.87% | +22.64% | 6.6B | |
| Weighted average by Cap. | +1.64% | -2.58% | -9.02% | +2.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.85B 298M 260M 240M 225M 421M 28.11B 425M 1.1B 13.82B 1.12B 1.09B 48.42B | 3.12B 326M 284M 263M 246M 461M 30.77B 465M 1.21B 15.13B 1.22B 1.2B 53.01B |
| Net income | 146M 15.24M 13.27M 12.28M 11.5M 21.55M 1.44B 21.71M 56.47M 707M 57.18M 55.96M 2.48B | 228M 23.78M 20.71M 19.17M 17.96M 33.64M 2.24B 33.89M 88.16M 1.1B 89.26M 87.35M 3.86B |
| Net Debt | 1.46B 153M 133M 123M 115M 216M 14.39B 217M 566M 7.08B 573M 560M 24.79B | 1.27B 132M 115M 107M 99.85M 187M 12.47B 188M 490M 6.13B 496M 486M 21.49B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
